M C 13 (Clonazepam 0.5 mg)
Pill imprint M C 13 has been identified as Clonazepam 0.5 mg.
Clonazepam is used in the treatment of anxiety; benzodiazepine withdrawal; bipolar disorder; panic disorder; borderline personality disorder (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Clonazepam 0.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- M C 13
- Strength:
- 0.5 mg
- Color:
- Yellow
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Benzodiazepine anticonvulsants
Benzodiazepines - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-1910
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
D&C Yellow No. 10
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0881 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
More about clonazepam
Consumer resources
- Other brands: Klonopin, Klonopin Wafer
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
